0001144204-16-104181.txt : 20160523
0001144204-16-104181.hdr.sgml : 20160523
20160523160310
ACCESSION NUMBER: 0001144204-16-104181
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20160523
DATE AS OF CHANGE: 20160523
EFFECTIVENESS DATE: 20160523
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neuralstem, Inc.
CENTRAL INDEX KEY: 0001357459
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 522007292
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-263688
FILM NUMBER: 161669027
BUSINESS ADDRESS:
STREET 1: 9700 GREAT SENECA HIGHWAY
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 3013664841
MAIL ADDRESS:
STREET 1: 9700 GREAT SENECA HIGHWAY
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
D
1
primary_doc.xml
X0707
D
LIVE
0001357459
Neuralstem, Inc.
20271 GOLDENROD LANE,
2ND FLOOR
GERMANTOWN
MD
MARYLAND
20876
3013664960
DELAWARE
None
None
Corporation
true
Richard
Daly
20271 Goldenrod Lane,
2nd floor
Germantown
MD
MARYLAND
20876
Executive Officer
Director
Karl
Johe
20271 Goldenrod Lane,
2nd floor
Germantown
MD
MARYLAND
20876
Executive Officer
Director
Jonathan
Lloyd Jones
20271 Goldenrod Lane,
2nd floor
Germantown
MD
MARYLAND
20876
Executive Officer
Scott
Ogilvie
20271 Goldenrod Lane,
2nd floor
Germantown
MD
MARYLAND
20876
Director
Stanley
Westreich
20271 Goldenrod Lane,
2nd floor
Germantown
MD
MARYLAND
20876
Director
Catherine
Sohn
20271 Goldenrod Lane,
2nd floor
Germantown
MD
MARYLAND
20876
Director
Sandford
Smith
20271 Goldenrod Lane,
2nd floor
Germantown
MD
MARYLAND
20876
Director
William
Oldaker
20271 Goldenrod Lane,
2nd floor
Germantown
MD
MARYLAND
20876
Director
Richard
Garr
20271 Goldenrod Lane,
2nd floor
Germantown
MD
MARYLAND
20876
Director
Biotechnology
Decline to Disclose
- 06b
false
2016-05-12
false
true
true
false
50000
1100000
1080000
20000
For every share purchased at a price of $0.40 per share, each investor received a warrant to purchase one share of common stock at an exercise price of $0.40 and a term of five years.
false
3
50000
0
Financial advisory fee of $50,000 was paid to Roth Capital Partners, LLC
0
false
Neuralstem, Inc.
/s/ Richard Daly
Richard Daly
Chief Executive Officer
2016-05-23